Sequential central retinal artery occlusion in two brothers: a fight to prevent blindness

David Oliver-Gutierrez1, Olaia Subirà2, Ana Zabalza3,4

  • 1Ophthalmology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. davidoliguti@gmail.com.

Abstract

Insights

Central retinal artery occlusion (CRAO) in young patients may signal rare genetic conditions like DADA2. This report details two brothers diagnosed with DADA2 after presenting with CRAO, highlighting the need for genetic testing in unexplained vascular cases.

Area of Science:

  • Ophthalmology
  • Genetics
  • Rheumatology

Background:

  • Central retinal artery occlusion (CRAO) is typically seen in older individuals with cardiovascular risk factors.
  • Younger patients with CRAO and no traditional risk factors warrant investigation for rare genetic disorders.
  • Adenosine deaminase 2 deficiency (DADA2) is a rare vasculitic disease that can present with vascular occlusions.

Purpose of the Study:

  • To report two cases of CRAO in young brothers.
  • To highlight the diagnostic challenges in identifying DADA2.
  • To emphasize the importance of genetic testing for rare vasculitic disorders presenting as CRAO.

Main Methods:

  • Case report of two brothers presenting with CRAO.
  • Extensive diagnostic workup including blood tests, imaging, and autoimmunity panels.
  • Genetic testing to identify mutations in the CECR1 gene.

Main Results:

  • Two brothers, aged 34 and 32, presented with CRAO eight years apart, with no significant prior medical history.
  • Initial extensive evaluations did not reveal common causes for CRAO.
  • Genetic testing confirmed a homozygous mutation in the CECR1 gene, diagnosing DADA2 in both patients.

Conclusions:

  • Young patients with unexplained CRAO should be evaluated for genetic disorders like DADA2.
  • DADA2 diagnosis can be challenging due to variable manifestations and can present initially as CRAO.
  • Early diagnosis and treatment with TNF inhibitors are crucial for preventing vision loss and systemic complications in DADA2.